A Major Role for the Fas Pathway in Acute Graft-Versus-Host Disease

Journal of Immunology

Volumn 157, Issue 12, 1996, Pages 5387-5393

  Via, Charles S ^a   Nguyen, Phuong ^a   Shustov, Andrei ^a   Drappa, Joern ^b   Elkon, Keith B ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FASL PROTEIN, MOUSE; INTERLEUKIN 2; MEMBRANE PROTEIN;

ACUTE DISEASE; ANIMAL; ARTICLE; BIOSYNTHESIS; C3H MOUSE; C57BL MOUSE; CELL DIVISION; CYTOLOGY; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD95; CELL DIVISION; FAS LIGAND PROTEIN; GRAFT VS HOST DISEASE; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; T-LYMPHOCYTES;

EID: 0030589301     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ferrara, J. L. M., and J. H. Deeg. 1991. Graft-versus-host disease. N. Engl. J. Med. 324:667.
2. Rosenberg, A. S., and A. Singer. 1992. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu. Rev. Immunol. 10:333.
3. Gleichmann, E., S. T. Pals, A. G. Relink, T. Radaszkiewicz, and H. Gleichmann. 1984. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today 5:324.
4. Via, C. S., and G. M. Shearer. 1988. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today 9:207.
5. Fujiwara, M., and A. Kariyone. 1984. One way occurrence of graft-vs-host disease in bone marrow chimeras between congenic MRL mice. Immunology 53: 251.
6. Theofilopoulos, A. N., R. S. Balderas, Y. Gozes, M. T. Aguado, L.-M. Hang, P. R. Morrow, and F. J. Dixon. 1985. Association of lpr gene with graft-vs.-host disease-like syndrome. J. Exp. Med. 162:1.
7. Perkins, D. L., J. Michaelson, and A. Marshak-Rothstein. 1987. The lpr gene is associated with resistance to engraftment by lymphoid but not erythroid stem cells from normal mice. J. Immunol. 138:466.
8. Chu, J. L., P. Ramoa, A. Rosendorff, J. Nikolic-Zugic, E. Lacy, A. Matsuzawa, and K. B. Elkon. 1995. Massive up-regulation of the fas ligand in lpr and gld mice: implications for fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181:393.
9. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoprolifetative disorders. EMBO J. 14:12.
10. Lowin, B., C. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370:650.
11. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
12. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell 76:969.
13. Roths, J. B., E. D. Murphy, and E. M. Eicher. 1984. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159:1.
14. Via, C. S. 1991. Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease. J. Immunol. 146:2603.
15. Malek, T. R., R. J. Robb, and E. M. Shevach. 1983. Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex. Proc. Natl. Acad. Sci. USA 80:5694.
16. Mosmann, T. R., R. L. Bond, R. L. Coffman, J. Ohara, and W. E. Paul. 1986. T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA 83:5654.
17. Unkeless, J. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
18. Via, C. S., and F. D. Finkelman. 1993. Critical role of interleukin-2 in the development of acute graft-versus-host disease. Int. Immunol. 5:565.
19. Glass, A. A., C. M. Walsh, D. H. Lynch, and W. R. Clark. 1996. Regulation of the fas lytic pathway in cloned CTL. J. Immunol. 156:3638.
20. + donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference. J. Immunol. 140:2600.
21. Via, C. S., J. D. Shanley, and G. M. Shearer. 1990. Synergistic effect of murine cytomegalovirus on the induction of acute graft-versus-host disease involving MHC class I differences only: analysis of in vitro T cell function. J. Immunol. 145:3283.
22. Singh, J. N., E. Sabbadini, and A. H. Schon. 1972 Cytotoxicity in graft-versus-host reaction. I. Role of donor and host spleen cells. J. Exp. Med. 136:39.
23. + T cells. J. Immunol. 155:2396.
24. Swain, S. L., L. M. Bradley, M. Croft, S. Tonkonogy, G. Atkins, A. D. Weinberg, D. D. Ducan, S. M. Hedrick, R. W. Dutton, and G. Huston. 1991. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123:115.
25. Davidson, W. F., C. Calkins, A. Hugin, T. Giese, and K. L. Holmes. 1991. Cytokine secretion by C3H-lpr and -gld T cells. J. Immunol. 146:4138.
26. Schultz, M., H. J. Schuurman, J. Joergensen, C. Steiner, T. Meerloo, D. Kagi, H. Hengartner, R. M. Zinkernagel, M. H. Schreier, K. Burki, and B. Lederman. 1995. Acute rejection of vascular heart allografts by perforin deficient mice. Eur. J. Immunol. 25:474.
27. Van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 Jigand-transduced costimulation of T cells in the development of helper function. Nature 378:620.
28. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
29. Braun, M. V., B. Lowin, F. Lars, H. Acha-Oreba, and J. Tschopp. 1996. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:657.
30. Ferrara, J. L. 1993. Cytokine dysregulation as a mechanism of graft-versus-host disease. Curr. Opin. Immunol. 5:794.
31. 1 model. FASEB J. 9:A499.
32. Alderson, M. R., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux. K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.
33. Mapara, M. Y., R. Bargou, C. Zugck, H. Dohner, F. Ustaoglu, R. R. Jonker, P. H. Krammer, and B. Dorken. 1993. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol. 23:702.
34. Aggarwal, B. B., S. Singh, R. LaPushin, and K. Totpal. 1995. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364:5.
35. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune response. Immunol. Today 16:569.
36. Hakim, F. T., R. Cepeda, G. S. Gray, C. H. June, and R. Abe. 1995. Acute graft-versus-host reaction can be aborted by blockade of costimulatory molecules. J. Immunol. 155:1757.
37. Hahne, M., M. C. Peitsch, M. Irmler, M. Schroter, B. Lowin, M. Rousseau, C. Bron, T. Renno, L. French, and J. Tschopp. 1995. Characterization of the non-functional fas ligand of gld mice. Int. Immunol. 7:1381.
38. Cayabyab, M., J. H. Phillips, and L. L. Lanier. 1994. CD40 preferentially co-stimulates activation of CD4 lymphocytes. J. Immunol. 152:1523.
39. Pollok, K. E., Y. J. Kim, J. Hurtado, Z. Zhou, K. K. Kim, and B. S. Kwon. 1994. 4-1BB T cell antigen binds to mature B cells and macrophages and co-stimulates anti-IgM primed splenic B cells. Eur. J. Immunol. 24:367.
40. Stuber, E., M. Neurath, D. Calderhead, H. P. Fell, and W. Strober. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in mature splenic B cells. Immunity 2:507.
41. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T cell-priming in mice lacking CD40 ligand. Nature 378:617.
42. Ren, R., B. J. Mayer, P. Cicchetti, and D. Baltimore. 1993. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259:1157.